Durcan E - Search Results

1

Is There A Connection Between Primary Hypophysitis and Celiac Disease?

Kara Z, Eşkazan T, Şahin S, Durcan E, Sulu C, Demir AN, Uysal S, Özkaya HM, Yılmaz E, Hatemi Aİ, Bolayırlı İM, Kadıoğlu P. Kara Z, et al. Among authors: durcan e. Exp Clin Endocrinol Diabetes. 2024 Jan;132(1):33-38. doi: 10.1055/a-2213-4375. Epub 2023 Nov 17. Exp Clin Endocrinol Diabetes. 2024. PMID: 37977557

2

Primary hypophysitis: Experience of a Single Tertiary Center.

Korkmaz OP, Sahin S, Ozkaya HM, Apaydin T, Durmaz ES, Haliloglu O, Durcan E, Kadioglu P. Korkmaz OP, et al. Among authors: durcan e. Exp Clin Endocrinol Diabetes. 2021 Jan;129(1):14-21. doi: 10.1055/a-0919-4388. Epub 2019 Jun 24. Exp Clin Endocrinol Diabetes. 2021. PMID: 31234218

3

Effectiveness of Cabergoline Treatment in Patients with Acromegaly Uncontrolled with SSAs: Experience of a Single Tertiary Center.

Sahin S, Fidan MC, Korkmaz OP, Durcan E, Ozkaya HM, Kadioglu P. Sahin S, et al. Among authors: durcan e. Exp Clin Endocrinol Diabetes. 2021 Sep;129(9):644-650. doi: 10.1055/a-1274-1276. Epub 2020 Oct 23. Exp Clin Endocrinol Diabetes. 2021. PMID: 33096579

4

Fibroblast Growth Factor Receptor-4 Expression in Pituitary Adenomas is Associated with Aggressive Tumor Features.

Durcan E, Keskin FE, Ozkaya HM, Sirolu S, Sahin S, Korkmaz OP, Gazioglu N, Tanriover N, Comunoglu N, Oz B, Kizilkilic O, Kadioglu P. Durcan E, et al. Exp Clin Endocrinol Diabetes. 2022 Feb;130(2):125-133. doi: 10.1055/a-1523-7216. Epub 2021 Jul 12. Exp Clin Endocrinol Diabetes. 2022. PMID: 34255320

5

The effect of somatostatin analogs and acromegaly on the upper gastrointestinal system.

Sahin S, Icli TB, Durcan E, Sulu C, Ozkaya HM, Hatemi AI, Kadioglu P. Sahin S, et al. Among authors: durcan e. Pituitary. 2021 Apr;24(2):184-191. doi: 10.1007/s11102-020-01095-3. Epub 2020 Oct 19. Pituitary. 2021. PMID: 33074400

6

Psychosocial effects and clinic reflections of the COVID-19 outbreak in patients with acromegaly and Cushing's disease.

Durcan E, Turan S, Sahin S, Sulu C, Taze SS, Kavla Y, Ozkaya HM, Kadioglu P. Durcan E, et al. Pituitary. 2021 Aug;24(4):589-599. doi: 10.1007/s11102-021-01136-5. Epub 2021 Mar 5. Pituitary. 2021. PMID: 33665771 Free PMC article.

7

Can "VAI" Better Indicate Metabolic Syndrome Compared with Other Metabolic Syndrome-Related Parameters in Patients with Thyroid Nodules? A Study from Turkey.

Durcan E, Sahin S, Dedeoglu SE, Ozkaya HM, Gonen MS. Durcan E, et al. Metab Syndr Relat Disord. 2021 Aug;19(6):358-366. doi: 10.1089/met.2020.0147. Epub 2021 Apr 1. Metab Syndr Relat Disord. 2021. PMID: 33794138

8

TransCOVID: Does Gender-Affirming Hormone Therapy Play a Role in Contracting COVID-19?

Durcan E, Turan S, Bircan BE, Yaylamaz S, Demirel O, Demir AN, Sulu C, Kara Z, Sahin S, Taze SS, Mefkure Ozkaya H, Kadioglu P. Durcan E, et al. J Sex Marital Ther. 2022;48(4):415-426. doi: 10.1080/0092623X.2021.2000535. Epub 2021 Nov 21. J Sex Marital Ther. 2022. PMID: 34806552

9

Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia.

Durcan E, Ozkan S, Saygi HI, Dincer MT, Korkmaz OP, Sahin S, Karaca C, Sulu C, Bakir A, Ozkaya HM, Trabulus S, Guzel E, Seyahi N, Gonen MS. Durcan E, et al. J Diabetes. 2022 Apr;14(4):236-246. doi: 10.1111/1753-0407.13261. Epub 2022 Feb 28. J Diabetes. 2022. PMID: 35229458 Free PMC article.

10

Effect of metformin on thyroid cancer risk in patients with acromegaly: A preliminary observational study.

Sulu C, Bektas AB, Guzel SS, Tay K, Sahin S, Durcan E, Ozkaya HM, Kadioglu P. Sulu C, et al. Among authors: durcan e. Growth Horm IGF Res. 2022 Oct;66:101484. doi: 10.1016/j.ghir.2022.101484. Epub 2022 Jun 30. Growth Horm IGF Res. 2022. PMID: 35870256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page